Disease/Infection News RSS Feed - Disease/Infection News

Researchers make important breakthrough in identifying major drivers of excessive coughing

Researchers make important breakthrough in identifying major drivers of excessive coughing

Cough treatments could change dramatically after the herpes virus helped researchers discover that the respiratory tract links to two different parts of the nervous system. [More]
Organoid Biobank for predicting cancer patient response to drugs

Organoid Biobank for predicting cancer patient response to drugs

Organoids, small clusters of cells that accurately mimic the behaviour of human tissue, can be used to test cancer drugs and, eventually, to identify effective personalised treatments for patients... [More]
South Asian Health Foundation wins BMJ “Diabetes team of the year” award

South Asian Health Foundation wins BMJ “Diabetes team of the year” award

The South Asian Health Foundation (SAHF) has been named ‘Diabetes Team of the Year’ at the prestigious 2015 BMJ Awards... [More]
Roche announces FDA clearance for cobas Cdiff Test to detect C. difficile in stool specimens

Roche announces FDA clearance for cobas Cdiff Test to detect C. difficile in stool specimens

Roche announced today that the US Food and Drug Administration has provided 510(k) clearance for the cobas Cdiff Test to detect Clostridium difficile (C. difficile) in stool specimens. [More]
Researchers create new vaccine development method for H5N1, H7N9 strains of avian influenza

Researchers create new vaccine development method for H5N1, H7N9 strains of avian influenza

A recent study with Kansas State University researchers details vaccine development for two new strains of avian influenza that can be transmitted from poultry to humans. The strains have led to the culling of millions of commercial chickens and turkeys as well as the death of hundreds of people. [More]
Breakthrough in fight against rare kidney disease - Membranous Nephropathy

Breakthrough in fight against rare kidney disease - Membranous Nephropathy

Scientists at The University of Manchester and Central Manchester University Hospitals NHS Foundation Trust have made a significant breakthrough in the fight against Membranous Nephropathy (MN) - a rare kidney disease which can lead to kidney failure. [More]
Lafora rare disease could be aggravated by oxidative stress

Lafora rare disease could be aggravated by oxidative stress

Neurodegenerative Lafora disease usually becomes apparent through seizures during adolescence and puberty and occurs as a consequence of defects in glycogen metabolism and in the cellular mechanisms that are responsible for its disposal. Researchers at the University of Valencia have led a study in which they propose that Lafora rare disease could be aggravated by oxidative stress. [More]
Sex-determining gene in mosquitoes may help reduce disease transmission

Sex-determining gene in mosquitoes may help reduce disease transmission

Researchers with the Fralin Life Science Institute at Virginia Tech have identified a gene responsible for sex determination in mosquitoes that can transmit yellow fever, dengue, and chikungunya viruses. [More]
GHIT Fund expands investments in leishmaniasis, diagnostic tests

GHIT Fund expands investments in leishmaniasis, diagnostic tests

The Global Health Innovative Technology Fund, which in the last two years has funded almost $32 million for innovative tools to tackle global infectious diseases, today announced additional investments of nearly $11 million that bring its portfolio to approximately $43 million. [More]
Research: Some immune cells convert into cells that trigger disease

Research: Some immune cells convert into cells that trigger disease

Researchers at Case Western Reserve University School of Dental Medicine have unraveled one of the mysteries of how a small group of immune cells work: That some inflammation-fighting immune cells may actually convert into cells that trigger disease. [More]
Risk prediction model can help target hepatitis C treatment to patients with most urgent need

Risk prediction model can help target hepatitis C treatment to patients with most urgent need

A team of researchers at the University of Michigan Health System has developed a risk prediction model that helps identify which hepatitis C patients have the most urgent need for new anti-viral drugs. [More]
Existing anti-stroke drug can be effective in treating middle-ear infections

Existing anti-stroke drug can be effective in treating middle-ear infections

An existing anti-stroke drug is an effective treatment for middle-ear infections, showing the ability to suppress mucus overproduction, improve bacterial clearance and reduce hearing loss, according to researchers at Georgia State University and the University of Rochester. [More]
ICS use may lower risk of mortality from pneumonia and other causes in COPD patients

ICS use may lower risk of mortality from pneumonia and other causes in COPD patients

Treatment of COPD with inhaled corticosteroids (ICS) may decrease the risk of dying from pneumonia and from other causes despite being associated with an increase in the occurrence of pneumonia, according to a new meta-analysis presented at the 2015 American Thoracic Society International Conference. [More]
Genocea reports positive results from GEN-003 Phase 2 clinical trial for treatment of genital herpes

Genocea reports positive results from GEN-003 Phase 2 clinical trial for treatment of genital herpes

Genocea Biosciences, Inc., a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced positive top-line data from a Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. [More]
Clinicians play key role in making consumers aware of the threats of foodborne diseases

Clinicians play key role in making consumers aware of the threats of foodborne diseases

Food safety awareness is key to understanding the food safety issues on the horizon, and clinicians at hospitals and doctors' offices play a key role in ensuring consumers are aware of the threats of foodborne illness, said the University of Georgia's Michael Doyle. [More]
Second-generation antibiotic shows promise against common bacterial infections

Second-generation antibiotic shows promise against common bacterial infections

Researchers led by St. Jude Children's Research Hospital scientists have developed a second-generation antibiotic that shows early effectiveness against common bacterial infections that pose a serious health threat to children and adults. [More]
CSGI joins with two California hospitals to eradicate deadly Clostridium difficile infections

CSGI joins with two California hospitals to eradicate deadly Clostridium difficile infections

Clean Sweep Group Inc., a Beverly Hills, CA, based microbial disinfection service company, joins with two California hospitals to significantly reduce deadly Clostridium difficile infections caught in their hospitals using ultraviolet (UV-C) germ-killing advanced disinfection devices. [More]
International study reveals that cold weather kills far more people than hot weather

International study reveals that cold weather kills far more people than hot weather

The study analysed over 74 million (74225200) deaths between 1985 and 2012 in 13 countries with a wide range of climates, from cold to subtropical... [More]
Researchers develop way to potentially predict future infectious disease outbreaks in humans

Researchers develop way to potentially predict future infectious disease outbreaks in humans

Researchers at the University of Georgia Odum School of Ecology have developed a way to predict which species of rodents are likeliest to be sources of new disease outbreaks in humans. Their study, which includes maps showing potential future disease hot spots, appears in the Proceedings of the National Academy of Sciences. [More]
Merus and Selexis receive a € 2.1 million grant for single cell line manufacturing of a bispecific antibody combination to treat colorectal cancer

Merus and Selexis receive a € 2.1 million grant for single cell line manufacturing of a bispecific antibody combination to treat colorectal cancer

Merus and Selexis will combine their unique and proprietary Oligoclonics® and SUREtechnology™ platforms respectively to develop a product combining two bispecific full length IgG antibodies that simultaneously targets and potently inhibits three receptor tyrosine kinases... [More]
Advertisement
Advertisement